首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).
【24h】

NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).

机译:重新审视了NSAID:与过氧化物酶体增殖物激活的伽玛受体(PPARgamma)相互作用的推定分子基础。

获取原文
获取原文并翻译 | 示例
           

摘要

This paper describes molecular docking studies of a series of classical NSAIDs with PPARgamma receptor, which has been pointed as a new target for the design of anti-cancer and anti-inflammatory drugs, and has been found to be responsible for some of the already established pharmacological effects observed for marketed drugs. The results show the molecular basis of PPARgamma activation by non-selective COX inhibitors.
机译:本文介绍了一系列具有PPARγ受体的经典NSAID的分子对接研究,该研究已被认为是设计抗癌和抗炎药物的新目标,并被发现与某些已经建立的药物有关市售药物的药理作用。结果显示了非选择性COX抑制剂激活PPARγ的分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号